IRIS
CORREALE, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.931
EU - Europa 2.761
AS - Asia 2.324
Continente sconosciuto - Info sul continente non disponibili 386
SA - Sud America 369
AF - Africa 74
OC - Oceania 2
Totale 9.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.840
SG - Singapore 938
IE - Irlanda 643
CN - Cina 624
RU - Federazione Russa 556
SE - Svezia 368
BR - Brasile 299
UA - Ucraina 276
HK - Hong Kong 252
IT - Italia 208
DE - Germania 202
VN - Vietnam 175
FR - Francia 174
IN - India 95
FI - Finlandia 80
AT - Austria 66
BD - Bangladesh 59
GB - Regno Unito 59
CZ - Repubblica Ceca 44
CA - Canada 43
TR - Turchia 38
IQ - Iraq 25
NL - Olanda 23
AR - Argentina 22
MX - Messico 22
ZA - Sudafrica 21
PK - Pakistan 20
ES - Italia 17
PL - Polonia 14
PH - Filippine 13
TN - Tunisia 13
EC - Ecuador 12
JP - Giappone 12
VE - Venezuela 10
UZ - Uzbekistan 9
EG - Egitto 8
KE - Kenya 8
CR - Costa Rica 7
JM - Giamaica 7
LT - Lituania 7
PE - Perù 7
BE - Belgio 6
CL - Cile 6
CO - Colombia 6
DZ - Algeria 6
ID - Indonesia 6
MA - Marocco 6
OM - Oman 6
AZ - Azerbaigian 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
IR - Iran 4
JO - Giordania 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
TH - Thailandia 4
MY - Malesia 3
PS - Palestinian Territory 3
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EU - Europa 2
HT - Haiti 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MK - Macedonia 2
NG - Nigeria 2
PR - Porto Rico 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 9.456
Salva come PNG Salva come JPEG
Città #
San Jose 895
Dublin 643
Ashburn 493
Singapore 426
Hong Kong 247
Nyköping 233
Beijing 204
Chandler 187
Jacksonville 172
Dallas 168
Santa Clara 142
Council Bluffs 119
Munich 103
Columbus 102
Lauterbourg 102
New York 85
Dearborn 72
Los Angeles 64
Princeton 64
Nanjing 61
Vienna 59
Moscow 55
Ho Chi Minh City 54
The Dalles 48
Wilmington 47
Hanoi 44
Helsinki 42
Phoenix 40
Frankfurt am Main 36
Seattle 35
Boardman 31
Brno 28
Turku 25
Nanchang 23
Falkenstein 22
Pune 22
Atlanta 21
Rome 20
São Paulo 20
London 19
Guangzhou 17
San Mateo 17
Brooklyn 16
Shanghai 16
Hillsboro 15
Nuremberg 15
Olomouc 15
Tianjin 15
Des Moines 14
Johannesburg 13
Palermo 13
San Francisco 13
Toronto 13
Assago 12
Chennai 12
Düsseldorf 12
Warsaw 12
Jiaxing 11
Milan 11
Shenyang 11
Da Nang 10
Mumbai 10
Washington 10
Amsterdam 9
Boston 9
Changsha 9
Foggia 9
Haiphong 9
Hangzhou 9
Montreal 9
Buffalo 8
Chicago 8
Denver 8
Jinan 8
Miami 8
Nairobi 8
Naples 8
Orem 8
Philadelphia 8
Renton 8
Tashkent 8
Tokyo 8
Tunis 8
Ann Arbor 7
Baghdad 7
Dhaka 7
Kunming 7
Lund 7
Mexico City 7
Stevenage 7
Woodbridge 7
Bari 6
Brussels 6
Gesualdo 6
Hebei 6
Paris 6
San José 6
Shenzhen 6
Acerra 5
Belo Horizonte 5
Totale 5.851
Salva come PNG Salva come JPEG
Nome #
Late onset of coronary vasospasm after administration of methyl-ergometrine for gynecologic bleeding. 165
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 155
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability 147
Alcohol-induced cardiac disease 145
"PAFIYAMA" syndrome; further evidence on a novel clinical entity 140
EXPRESS: Don't stop at first glance; pulmonary artery angiosarcoma mimicking chronic thromboembolic pulmonary hypertension 140
Cardiopulmonary exercise test predicts right heart catheterization 132
Delirium in heart failure 132
Typical Takotsubo syndrome and McConnell's phenomenon: What else lies beneath? 130
Influence of Heart Rate on Left and Right Ventricular Longitudinal Strain in Patients with Chronic Heart Failure 127
Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability 124
Chronic thromboembolic pulmonary hypertension. 123
Tissue Doppler Imaging predicts central sleep apnea in patients with chronic heart failure: data from the Daunia Registry 123
Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia 121
Liver disease and heart failure: Back and forth 121
Biomarkers in cardiorenal syndrome 121
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis 118
Inferior ST-Elevation Acute Myocardial Infarction or an Inferior-Lead Brugada-like Electrocardiogram Pattern Associated With the Use of Pregabalin and Quetiapine? 117
Redefining biomarkers in heart failure 116
Malignancies and outcome in Takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy 115
Fenofibrate and Dyslipidemia: Still a Place in Therapy? 115
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure 115
Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure 114
Tako-Tsubo cardiomyopathy in a teen girl with pheochromocytoma. 114
New Targets in Heart Failure Drug Therapy 114
Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis 110
Liver disease and heart failure: an uptodate 110
Recurrent Tako-Tsubo cardiomyopathy apparently induced by opposite triggers 109
Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction 106
"ischemic" ST elevation in a woman with left ventricular hypertrophy 106
Novel AKAP9 mutation and long QT syndrome in a patient with torsades des pointes 106
Cardiac contractility modulation in left ventricular systolic dysfunction: trick or treat? 104
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: Where do we stand? 102
Tako-Tsubo cardiomyopathy recurrence in an elderly woman firstly diagnosed with acute myocardial infarction: How many cold cases to be reclassified? 101
Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan 101
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 101
Advanced heart failure: non-pharmacological approach 100
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic 100
Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry 98
Echocardiographic score for prediction of pulmonary hypertension at catheterization: The Daunia Heart Failure Registry 98
Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease 98
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability 98
Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure 98
Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use? 97
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 97
COMPASS vs PEGASUS approach in a comparative budget impact analysis 96
Delirium in heart failure 95
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials 94
Biomarker profiles that differentiate type-1 and type 2 myocardial infarction 94
SAT0325 Nailfold capillaroscopic changes in patients with idiopathic and systemic sclerosis-related pulmonary arterial ipertension 93
Effects of Sacubitril/Valsartan on the Renal Resistance Index 92
Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation 92
Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management 91
Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry 91
HIV-associated pulmonary arterial hypertension: from bedside to the future 89
Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization 87
Impact of Frailty on Outcome of Older Patients With Non-ST Elevation Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention 86
Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction 85
The thromboembolism in COVID-19: the unsolved problem 84
Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure 83
Tako-Tsubo cardiomyopathy or allergic acute coronary syndrome: that is the question. 82
Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction 82
The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction 80
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 79
Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers 77
Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches 77
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy 76
Relationship between the strain measures of left atrial function and heart failure worsening 76
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 76
Atrial paced rhythm and heart rate-dependent worsening of left atrial and ventricular function 76
Gastrointestinal bleeding and coagulation disorders in a patient with left-ventricular assist device 76
Combined peripheral and central ultrasound for the diagnosis of PAH-SSc patients 74
Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender 74
Switch to Gliflozins and Biventricular Function Improvement in Patients with Chronic Heart Failure and Diabetes Mellitus 74
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 72
Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets 71
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies 71
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 71
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan 70
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study) 69
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension 69
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials 69
Endothelial Function Correlates With Pulmonary Pressures in Subjects With Clinically Suspected Pulmonary Hypertension 68
SGLT2 Inhibitors Introduction and Changes of the Other Disease Modifiers’ Drugs in Heart Failure Patients: A Single Center Real World Experience 68
Acute coronary syndrome with single‑lead ST segment elevation: A rare presentation of multivessel coronary artery disease 68
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach 68
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 67
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 67
Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside 67
LEAP Virtual Visit Assessment (VIVA): A structured protocol for virtual visits for patients with heart failure 65
Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target 64
Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging 63
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 62
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 61
Alcohol consumption and subclinical and clinical coronary heart disease: New insight into potential causal mechanisms 59
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin–angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 59
SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century? 57
Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience 57
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension 56
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 55
Totale 9.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022382 0 0 0 3 70 14 11 38 49 86 6 105
2022/20231.331 117 69 83 38 31 104 2 86 702 10 40 49
2023/2024585 57 18 39 19 79 124 13 94 1 11 14 116
2024/20251.735 88 18 28 77 50 243 159 115 456 153 198 150
2025/20263.844 310 321 444 304 194 186 720 433 316 314 152 150
2026/2027803 68 287 309 139 0 0 0 0 0 0 0 0
Totale 9.847